Patterns and serial changes in electrodiagnostic abnormalities of axonal Guillain-Barré syndrome

Neurology

Volumn 64, Issue 5, 2005, Pages 856-860

  Hiraga, A ^a,c   Kuwabara, S ^a   Ogawara, K ^a   Misawa, S ^a   Kanesaka, T ^a   Koga, M ^b   Yuki, N ^b   Hattori, T ^a   Mori, M ^a  

^a CHIBA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b DOKKYO MEDICAL UNIVERSITY   (Japan)

^c CHIBA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTI GANGLIOSIDE ANTIBODY; ANTIBODY; UNCLASSIFIED DRUG;

AACUTE MOTOR AXONAL NEUROPATHY; ACUTE INFLAMMATOR DEMELINATING POLYNEUROPATHY; ADULT; ARTICLE; DEMYELINATION; ELECTRODIAGNOSIS; ELECTROPHYSIOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FISHER EXACT TEST; GUILLAIN BARRE SYNDROME; HUMAN; IMMUNOASSAY; LATENT PERIOD; MAJOR CLINICAL STUDY; MALE; MUSCLE ACTION POTENTIAL; NERVE BLOCK; NERVE CONDUCTION; NERVE FIBER DEGENERATION; PRIORITY JOURNAL; RANK SUM TEST;

EID: 14644439823     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000153071.71335.E9     Document Type: Article

References (26)

1. Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barré polyneuropathy. Brain 1986;109:1115-1126.
2. McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993;33:333-342.
3. Griffin JW, Li CY, Ho TW, et al. Guillain-Barré syndrome in northern China: the spectrum of neuropathological changes in clinically defined cases. Brain 1995;118:577-595.
4. Ho TW, Mishu B, Li CY, et al. Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995;118:597-605.
5. 1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection. Ann Neurol 1995;38:809-816.
6. Hadden RD, Cornblath DR, Hughes RA, et al. Electrophysiological classification of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 1998;44:780-788.
7. Albers JW, Donofrio PD, McGonagle TK. Sequential electrodignostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985;8:528-539.
8. Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barré syndrome. Philadelphia: Davis, 1991.
9. Kusunoki S, Chiba A, Kon K, et al. N-Acetylgalactosaminyl GD1a is a target molecule for serum antibody in Guillain-Barré syndrome. Ann Neurol 1994;35:570-576.
10. Kuwabara S, Yuki N, Koga M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barré syndrome. Ann Neurol 1998;44:202-208.
11. Ho TW, Willison HJ, Nachamkin I, et al. Anti-GD1a antibody is associated with axonal but not demyelinating forms of Guillain-Barré syndrome. Ann Neurol 1999;45:168-173.
12. Yuki N, Ho TW, Tagawa Y, et al. Autoantibodies to GM1b and GalNAc-GD1a: relationship to Campylobacter jejuni infection and acute motor axonal neuropathy in China. J Neurol Sci 1999;164:134-138.
13. Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I. Guillain-Barré syndrome with antibody to a ganglioside, N-acetylgalactosaminyl GD1a. Brain 2000;123:116-124.
14. Kuwabara S, Ogawara K, Mizobuchi K, et al. Isolated absence of F waves and proximal axonal dysfunction in Guillain-Barré syndrome with antiganglioside antibodies. J Neurol Neurosurg Psychiatry 2000;68:191-195.
15. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 2000;48:624-631.
16. Yuki N, Ang CW, Koga M, et al. Clinical features and response to treatment in Guillain-Barré syndrome associated with antibodies to GM1b ganglioside. Ann Neurol 2000;47:314-321.
17. Ogawara K, Kuwabara S, Koga M, Mori M, Yuki N, Hattori T. Anti-GM1b IgG antibody is associated with acute motor axonal neuropathy and Campylobacter jejuni infection. J Neurol Sci 2003;210:41-45.
18. Kuwabara S, Ogawara K, Sung JY, et al. Differences in membrane properties of axonal and demyelinating Guillain-Barré syndromes. Ann Neurol 2002;52:180-187.
19. Asbury AK, Cornblath DR. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 1990;27(suppl):S21-S24.
20. Hughes RAC, Newsom-Davis JM, Perkin GD, Pierce JM. Controlled trial of prednisolone in acute polyneuropathy. Lancet 1978;2:750-753.
21. Rees JH, Soudain SE, Gregson NA, Hughes RAC. Campylobacter jejuni infection and Guillain-Barré syndrome. N Engl J Med 1995;333:1374-1379.
22. Hirabayashi Y, Handa S. Close association of Guillian-Barré syndrome with antibodies to minor monosialogangliosides GM1b and GM1α. J. Neuroimmunol 1997;74:30-34.
23. Burke D, Kiernan MC, Bostock H. Excitability of human axons. Clin Neurophysiol 2001;112:1575-1585.
24. Olsson Y. Microenvironment of the peripheral nervous system under normal and pathological conditions. Crit Rev Neurobiol 1990;5:265-311.
25. Capasso M, Caporale CM, Pomilio F, Gandolfi P, Lugaresi A, Uncini A. Acute motor conduction block neuropathy: another Guillain-Barré syndrome variant. Neurology 2003;61:617-622.
26. Lefaucheur J-P, Gregson NA, Gray I, von Raison F, Bertocchi M, Créange A. A variant of multifocal motor neuropathy with acute, generalised presentation and persistent conduction blocks. J Neurol Neurosurg Psychiatry 2003;74:1555-1561.